Latest market price
31.26
-0.81-2.53%
ARQTQT64Arcutis Biotherapeutics, Inc.·NASDAQ
31.26-2.53%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 20268-KCurrent report
Oct 28, 20264Statement of changes in beneficial ownership
Oct 28, 20263Initial statement of beneficial ownership
Oct 19, 20264Statement of changes in beneficial ownership
Oct 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 18, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 24, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 13, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20268-KCurrent report
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Jul 17, 20263Initial statement of beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership